MAD2 inhibitors, also referred to as MAD2_Mad2 inhibitors, are a class of chemical compounds specifically designed to target and inhibit the function of the Mitotic Arrest Deficient 2 (MAD2) protein, a key component of the spindle assembly checkpoint (SAC). The SAC is a critical surveillance mechanism that ensures the accurate segregation of chromosomes during mitosis by preventing the onset of anaphase until all chromosomes are properly attached to the mitotic spindle. MAD2 is essential for this checkpoint; it interacts with the mitotic checkpoint complex (MCC) to inhibit the anaphase-promoting complex/cyclosome (APC/C), thereby delaying the progression of the cell cycle until the correct spindle attachments are made. By inhibiting MAD2, researchers can disrupt this checkpoint, leading to premature progression through mitosis, which can result in chromosome missegregation and aneuploidy.
In research settings, MAD2 inhibitors are valuable tools for studying the mechanisms underlying the spindle assembly checkpoint and the broader implications of its disruption on cell division and genomic stability. By blocking MAD2 activity, scientists can investigate how the inhibition affects the fidelity of chromosome segregation and the consequences of bypassing the spindle checkpoint. This can provide insights into the role of MAD2 in maintaining chromosomal integrity during mitosis and the cellular responses to mitotic errors, such as apoptosis or senescence. Additionally, MAD2 inhibitors allow researchers to explore the interactions between MAD2 and other components of the SAC, as well as its regulation by upstream signals and its integration with other cell cycle checkpoints. Through these studies, the use of MAD2 inhibitors enhances our understanding of mitotic regulation, the maintenance of genomic stability, and the complex control mechanisms that ensure accurate cell division.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Reversine | 656820-32-5 | sc-203236 | 5 mg | $217.00 | 13 | |
A small molecule inhibitor that targets MAD2 and other proteins involved in the spindle checkpoint. It has shown potential as an antimitotic agent in cancer research. | ||||||
PRIMA-1MET | 5291-32-7 | sc-361295 sc-361295A | 10 mg 25 mg | $150.00 $319.00 | 5 | |
While primarily known for its reactivation of mutant p53, PRIMA-1Met has been reported to inhibit MAD2, leading to mitotic catastrophe in cancer cells. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
A potent inhibitor of Aurora kinases that indirectly affects MADBy inhibiting Aurora B kinase, ZM447439 disrupts proper chromosome alignment, leading to MAD2 activation and mitotic arrest. | ||||||
TNP 470 | 129298-91-5 | sc-296547 | 10 mg | $230.00 | ||
An anti-angiogenic drug that affects multiple pathways, including inhibiting MADIt has shown potential in limiting cancer growth and metastasis. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $115.00 $415.00 | 10 | |
An antibiotic with potential anticancer properties. It has been reported to inhibit MAD2 and induce mitotic arrest in cancer cells. | ||||||
Combrestatin A4 | 117048-59-6 | sc-204697 sc-204697A | 1 mg 5 mg | $45.00 $79.00 | ||
While primarily known as a vascular disrupting agent, CA-4 has been reported to target MAD2, leading to mitotic spindle disruption. | ||||||
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
An inhibitor of kinesin-5 motor protein that disrupts spindle formation and activates the spindle checkpoint, involving MAD2. | ||||||
Noscapine hydrochloride | 912-60-7 | sc-203650 sc-203650A | 100 mg 1 g | $20.00 $66.00 | ||
A microtubule-modulating agent that influences spindle dynamics and activates the spindle checkpoint through interactions with MAD2. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A widely used chemotherapeutic agent that affects multiple cellular processes. It has been reported to induce mitotic arrest and MAD2 activation in cancer cells. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $61.00 $85.00 | 4 | |
An inhibitor of Aurora kinases that indirectly affects MADInhibition of Aurora B kinase can lead to mitotic arrest and MAD2 activation. | ||||||